... GVHD Graft-versus-host disease 移植物抗宿主病 HAI Hepatic artery infusion 肝动脉灌注 HBV Hepatitis B virus 乙型肝炎病毒 ...
基于10个网页-相关网页
...理深度交流 radiation therapy, 3DCRT）联合TACE术对晚期肝癌的治疗发现，与3DCRT+肝动脉插管药物灌注（hepatic artery infusion, HAI）相比，3DCRT+TACE可提高肿瘤局部控制率（P<0.05），0.5、1.0、2.0年生存率分别为..
基于8个网页-相关网页
...栓的治疗进展_毕业论文网 疗栓塞(transcatheter arterial chemoembolization，TACE)或术中肝动脉置管(hepatic artery infusion，HAI)和(或)门静脉置管(portal vein infusion，PVI)]。
基于2个网页-相关网页
...栓的治疗进展_毕业论文网 疗栓塞(transcatheter arterial chemoembolization，TACE)或术中肝动脉置管(hepatic artery infusion，HAI)和(或)门静脉置管(portal vein infusion，PVI)]。
基于2个网页-相关网页
hepatic artery infusion chemotherapy 肝动脉灌注化疗
hai hepatic artery infusion 肝动脉灌注
hepatic artery infusion chemotlaerapy 肝动脉灌注化疗
hepatic artery infusion and embolization 肝动脉药物灌注和栓塞
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
应用推荐